Cabozantinib Treatment in a Phase II Study for Patients With Hepatocellular Carcinoma (HCC) Refractory to PD-1 Inhibitors
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Cabozantinib
Related studies linked through entity extraction aliases.
A Study of Pralsetinib Versus Standard of Care (SOC) for Treatment of RET-Mutated Medullary Thyroid Cancer (MTC).
- Status
- WITHDRAWN
- Phase
- PHASE3
Cabozantinib With Topotecan-Cyclophosphamide
- Status
- COMPLETED
- Phase
- PHASE1
Real-world Treatment Patterns and Outcomes Among aRCC Patients on Cabozantinib or Axitinib in England
- Status
- COMPLETED
- Phase
- N/A
Cabozantinib in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC)
- Status
- TERMINATED
- Phase
- PHASE2
Cabozantinib in Hepatocellular Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Cabozantinib Combined With PD-1 and CTLA-4 Inhibition in Metastatic Soft Tissue Sarcoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Compare Bempegaldesleukin (BEMPEG: NKTR-214) Combined With Nivolumab and Tyrosine Kinase Inhibitor (TKI) to Nivolumab and TKI Alone in Participants With Previously Untreated Kidney Cancer That is Advanced or Has Spread
- Status
- COMPLETED
- Phase
- PHASE1
A Trial of Cabozantinib in Patients With Advanced, Low Proliferative NEN G3
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Cabozantinib for Patients with Hepatocellular Carcinoma (HCC) Refractory to First Line Treatment
- Status
- COMPLETED
- Phase
- PHASE2
Spanish Real-World Evidence Cabozantinib
- Status
- COMPLETED
- Phase
- N/A
Cabozantinib in Patients With Advanced Hepatocellular Carcinoma With Child Pugh Class B Cirrhosis After First-Line Therapy
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Cabozantinib and Abiraterone With Checkpoint Inhibitor Immunotherapy in Metastatic Hormone Sensitive Prostate Cancer (CABIOS Trial)
- Status
- COMPLETED
- Phase
- PHASE1
Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Study of Atezolizumab in Combination With Cabozantinib Versus Docetaxel in Patients With Metastatic Non-Small Cell Lung Cancer Previously Treated With an Anti-PD-L1/PD-1 Antibody and Platinum-Containing Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Safety, Tolerability and Efficacy of Cabozantinib in Patients With Hepatocellular Carcinoma and Impaired Liver Function
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Trial Aiming to Assess the Safety and Activity of the Combination of Cabozantinib Plus Lanreotide in GEP and NET
- Status
- UNKNOWN
- Phase
- PHASE2
Cabozantinib in the Elderly With Metastatic Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- N/A